"human epidermal growth factor receptor type 2" trang 3 - tải miễn phí từ tailieuXANH
Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China

Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China
7    49    0
Frequency of Her2/neu expression in colorectal adenocarcinoma: A study from developing South Asian Country

Frequency of Her2/neu expression in colorectal adenocarcinoma: A study from developing South Asian Country
7    70    0
Biopsy of breast cancer metastases: Patient characteristics and survival

Biopsy of breast cancer metastases: Patient characteristics and survival
9    59    0
Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): A multicenter, phase II trial

Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): A multicenter, phase II trial
9    59    0
Atypical ubiquitin ligase RNF31: The nuclear factor modulator in breast cancer progression

Atypical ubiquitin ligase RNF31: The nuclear factor modulator in breast cancer progression
8    73    0
A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer

A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer
9    51    0
UPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R

UPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R
12    62    0
Decreased expression of stomatin predicts poor prognosis in HER2-positive breast cancer

Decreased expression of stomatin predicts poor prognosis in HER2-positive breast cancer
8    64    0
Prognostic value of ERBB4 expression in patients with triple negative breast cancer

Prognostic value of ERBB4 expression in patients with triple negative breast cancer
12    71    0
Aggressive breast cancer in western Kenya has early onset, high proliferation, and immune cell infiltration

Aggressive breast cancer in western Kenya has early onset, high proliferation, and immune cell infiltration
15    72    0
Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California teachers study

Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California teachers study
8    46    0
Long-term survival and BRCA status in male breast cancer: A retrospective single-center analysis

Long-term survival and BRCA status in male breast cancer: A retrospective single-center analysis
11    71    0
Expansive hematoma in delayed cerebral radiation necrosis in patients treated with T-DM1: A report of two cases

Expansive hematoma in delayed cerebral radiation necrosis in patients treated with T-DM1: A report of two cases
5    66    0
Patterns of resource utilization and cost for postmenopausal women with hormonereceptor–positive, human epidermal growth factor receptor-2–negative advanced breast cancer in Europe

Patterns of resource utilization and cost for postmenopausal women with hormonereceptor–positive, human epidermal growth factor receptor-2–negative advanced breast cancer in Europe
12    74    0
Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells

Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells
9    62    0
Effectiveness of the AJCC 8th edition staging system for selecting patients with T1–2N1 breast cancer for post-mastectomy radiotherapy: A joint analysis of 1986 patients from two institutions

Effectiveness of the AJCC 8th edition staging system for selecting patients with T1–2N1 breast cancer for post-mastectomy radiotherapy: A joint analysis of 1986 patients from two institutions
11    64    0
Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors

Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors
19    51    0
The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: A retrospective study in 107 patients

The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: A retrospective study in 107 patients
7    63    0
Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status

Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status
13    52    0
Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients

Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients
12    68    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.